Company: BDRX
Filing Date: 2025-04-11
Form Type: 20-F
Source: 0001214659-25-005742
Chunk: 4

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-11
Form: 20-F
Item: Item 6
Chunk 4
---
DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES.

  Directors and Senior Management  

The following table sets forth
certain information about our current directors and senior management. The professional address of each of the directors and officers
is care of Biodexa Pharmaceuticals PLC, Caspian Point, 1 Caspian Way, Cardiff, CF10 4DQ, United Kingdom.

  Name (1)                                       Age at      Position/Title                                                 
                                                                                                                            
                                             12/31/2024                                                                     
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Stephen Stamp                                      63      Chief Executive Officer and Chief Financial Officer, Director  
  Stephen Parker (3)(4)                              66      Non-Executive Chairman of the Board of Directors               
  Simon Turton, Ph. D. (2)(3)(4)                     57      Senior Independent Non-Executive Director                      
  Sijmen (Simon) de Vries, M. D. (2)(4)              65      Non-Executive Director                                         
  Ann Merchant (2)(3)                                59      Non-Executive Director                                         

__________________________

  (1)      The term of the Board of Directors will expire immediately after the annual general meeting held in 2027  
           for Dr. de Vries, 2026 for Mr. Stamp, Dr. Parker and Ms. Merchant, and 2025 for Dr. Turton.               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (2)      Remuneration Committee member  

  (3)      Audit Committee member  

  (4)      Nominations Committee member  

Stephen Stamphas served
as our Chief Executive Officer since March 31, 2020, and our Chief Financial Officer and a member of our Board of Directors since September
2019. Prior to joining the Company, Mr. Stamp served as Chief Executive Officer of Ergomed plc (AIM: ERGO) from December 2017 until January
2019 and Chief Financial Officer from January 2016 to July 2018. From March 2013 until July 2015, Mr. Stamp served as the Chief Financial
Officer of Assurex Health, Inc. Mr. Stamp served as Chief Financial Officer of EZCORP Inc. (NASDAQ: EZPW) and KV Pharmaceuticals Co. from
November 2010 to October 2012 and March 2010